𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Single-agent paclitaxel in patients with previously untreated stage IV epithelial ovarian cancer

✍ Scribed by Gore, ME; Rustin, G; Slevin, M; Gallagher, C; Penson, R; Osborne, R; Ledermann, J; Cameron, T; Thompson, JM

Book ID
109837363
Publisher
Nature Publishing Group
Year
1997
Tongue
English
Weight
927 KB
Volume
75
Category
Article
ISSN
0007-0920

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Consolidation hyperthermic intraperitone
Consolidation hyperthermic intraperitoneal chemotherapy using paclitaxel in patients with epithelial ovarian cancer
✍ Jin Hwi Kim; Joon Mo Lee; Ki Sung Ryu; Yong Seok Lee; Yong Gyu Park; Soo Young H πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 137 KB

## Abstract ## Background We evaluated the efficacy and feasibility of hyperthermic intraperitoneal chemotherapy (HIPEC) using paclitaxel as consolidation therapy in patients with epithelial ovarian cancer. ## Methods Between November 1999 and January 2004, 18 patients with a negative second‐loo

Phase II trial of irinotecan, paclitaxel
Phase II trial of irinotecan, paclitaxel and carboplatin in patients with previously untreated Stage IIIB/IV nonsmall cell lung carcinoma
✍ Mark A. Socinski; Alan B. Sandler; Valerie K. Israel; Heidi H. Gillenwater; Lang πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 86 KB πŸ‘ 1 views

## Abstract ## BACKGROUND This Phase II multicenter, open‐label, single‐arm study evaluated the efficacy and safety of a three‐drug combination of irinotecan (CPT‐11), paclitaxel, and carboplatin in advanced nonsmall cell lung carcinoma (NSCLC). ## METHODS Patients received repeated 21‐day cycle